Glucocorticoid-induced osteoporosis in patients with rheumatic diseases: clinical characteristics, associated factors, and fragility fractures.

Ok NF, Duruöz MT, Gezer HH

Open source

DOI
10.1007/s10067-026-08521-0
Published
2026 Nov 6
Container
Clinical rheumatology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10067-026-08521-0,
  title = {Glucocorticoid-induced osteoporosis in patients with rheumatic diseases: clinical characteristics, associated factors, and fragility fractures.},
  author = {Ok NF and Duruöz MT and Gezer HH},
  year = {2026},
  journal = {Clinical rheumatology},
  doi = {10.1007/s10067-026-08521-0},
  url = {https://doi.org/10.1007/s10067-026-08521-0}
}

RIS

TY  - JOUR
TI  - Glucocorticoid-induced osteoporosis in patients with rheumatic diseases: clinical characteristics, associated factors, and fragility fractures.
AU  - Ok NF
AU  - Duruöz MT
AU  - Gezer HH
PY  - 2026
JO  - Clinical rheumatology
DO  - 10.1007/s10067-026-08521-0
UR  - https://doi.org/10.1007/s10067-026-08521-0
ER  - 

APA

NF, O., MT, D., & HH, G. (2026). Glucocorticoid-induced osteoporosis in patients with rheumatic diseases: clinical characteristics, associated factors, and fragility fractures.. Clinical rheumatology. https://doi.org/10.1007/s10067-026-08521-0

Source records